Regulatory T cells in rheumatoid arthritis showed increased plasticity toward Th17 but retained suppressive function in peripheral blood

Annals of the Rheumatic Diseases

Volumn 74, Issue 6, 2015, Pages 1293-1301

  Wang, Tian ^a,b   Sun, Xiaolin ^a   Zhao, Jing ^a   Zhang, Jing ^a   Zhu, Huaqun ^a   Li, Chun ^a   Gao, Na ^b   Jia, Yuan ^a   Xu, Dakang ^c,d   Huang, Fang Ping ^e   Li, Ningli ^f   Lu, Liwei ^g   Li, Zhan Guo ^a   Kvien, Tore K ^h  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c MONASH UNIVERSITY   (Australia)

^d HANGZHOU NORMAL UNIVERSITY   (China)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

^f SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^g UNIVERSITY OF HONG KONG   (Hong Kong)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TH17 CELL; ADULT; AGED; CASE CONTROL STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-17; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84935005309     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204228     Document Type: Article

References (30)

1. Chang SH, Reynolds JM, Pappu B.P., et al. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 2011; 35:611-21.
2. Qian Y, Liu C, Hartupee J., et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol 2007; 8:247-56.
3. Chen G, Li N, Zhang D., et al. Immunological profile and regulatory mechanism induced by vaccination with selected synovial T cells in rheumatoid arthritis. Arthritis Rheum 2007; 56:453-63.
4. Zhang R, Huynh A, Whitcher G., et al. An obligate cell-intrinsic function for CD28 in Tregs. J Clin Invest 2013; 123:580-93.
5. Lin J, Zhou Z, Huo R., et al. Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis. J Immunol 2012; 188:5776-84.
6. Zhang Q, Wu J, Cao Q., et al. A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 2009; 60:3602-12.
7. Harrington LE, Hatton RD, Mangan P.R., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-32.
8. Park JS, Lim MA, Cho M.L., et al. p53 controls autoimmune arthritis via the STAT3/ STAT5-mediated regulation of the Th17-Treg balance. Arthritis Rheum 2012; 65:949-59.
9. Chabaud M, Fossiez F, Taupin J.L., et al. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. J Immunol 1998; 161:409-14.
10. Yagi H, Nomura T, Nakamura K., et al. Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol 2004; 16:1643-56.
11. Papiernik M, de Moraes ML, Pontoux C, et al. Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 1998; 10:371-8.
12. Dieckmann D, Plottner H, Berchtold S., et al. Ex vivo isolation and characterization of CD4 (+)CD25 (+) T cells with regulatory properties from human blood. J Exp Med 2001; 193:1303-10.
13. Bettelli E, Carrier Y, Gao W., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-8.
14. Yang XO, Nurieva R, Martinez G.J., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cells programs. Immunity 2008; 29:44-56.
15. Zhou L, Lopes JE, Chong M.M., et al. TGF-β-induced FoxP3 inhibits Th17 cell differentiation by antagonizing RORγt function Nature 2008; 453:236-40.
16. Koenen HJ, Smeets RL, Vink P.M., et al. Human CD25high FoxP3+ regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112:2340-52.
17. Hovhannisyan Z, Treatman J, Littman D.R., et al. Characterization of IL-17 producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011; 140:957-65.
18. Beriou G, Costantino CM, Ashley C.W., et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113:4240-9.
19. Valmori D, Raffin C, Raimbaud I., et al. Human RORγt+TH17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci USA 2010; 107:19402-7.
20. Miyara M, Yoshioka Y, Kitoh A., et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the Foxp3 transcription factor. Immunity 2009; 30:899-911.
21. Cosmi L, Palma RD, Santarlasci V, et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 2008; 205:1903-16.
22. Abdulahad WH, Boots AMH, Kallenberg CGM. FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells. Rheumatology 2011; 50:646-56.
23. Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease. Nat Med 2011; 17:673-5.
24. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44-8.
25. Walter GJ, Evans HG, Menon B, et al. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45RO +CD25+CD127low regulatory T cells. Arthritis Rheum 2013; 65:627-38.
26. Petrovic-Rackov L, Pejnovic N. Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis. Clin Rheumatol 2006; 25:448-52.
27. Boissier MC, Semerano L, Challal S., et al. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction. J Autoimmun 2012; 39:222-8.
28. Nie H, Zheng Y, Li R., et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nat Med 2013; 19:322-8.
29. Nishihara M, Ogura H, Ueda N., et al. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 2007; 19:695-702.
30. McGeachy MJ, Chen Y, Tato C.M., et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol 2009; 10:314-24.